If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.50
Bid: 137.90
Ask: 138.00
Change: 1.45 (1.07%)
Spread: 0.10 (0.073%)
Open: 136.35
High: 138.55
Low: 136.35
Prev. Close: 136.05
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Jan 2023 07:00

RNS Number : 4629M
Centrica PLC
12 January 2023
 

12 January 2023

Centrica plc

Directorate Change

Centrica plc announces that Russell O'Brien will be appointed Group Chief Financial Officer (CFO) and an Executive Director on 1 March 2023. Kate Ringrose will step down as CFO and an Executive Director on 28 February 2023 and is expected to leave Centrica towards the end of 2023 after an orderly transition.

Chris O'Shea, Centrica Group Chief Executive, said:

"I want to pay tribute to Kate's achievements during almost 20 years at Centrica and to thank her for the unstinting support she's given me during my time as both CFO and CEO. Kate has made a significant contribution to the company and helped steer us through a challenging external landscape. Kate leaves with our very best wishes for the future.

Centrica has made significant progress over the last three years and is now more efficient and competitive. We have a focussed portfolio of complementary businesses with a transformed balance sheet, and we are now well placed to drive growth across the portfolio and deliver improved shareholder returns.

I'm delighted that we have been able to secure someone of Russell's calibre to be our new CFO. In his long-standing role as Group Treasurer at Shell, Russell was instrumental in delivering shareholder value and setting a clear financial framework for investors. Russell's broad experience across the energy value chain, including roles as global CFO for both Shell's Integrated Gas and Retail businesses, will be a huge asset to Centrica as we look to accelerate the creation of shareholder value whilst helping decarbonise the energy system."

Kate Ringrose, outgoing Group Chief Financial Officer, said:

"It has been an absolute privilege to be part of the team delivering the turnaround of Centrica. I have enjoyed my time with the company immensely but after almost 20 years it is now time for a new challenge. I have every confidence that the company is on the right track and I'd like to wish Chris, Russell and the rest of the Centrica team all the very best for the future."

Russell O'Brien, incoming Group Chief Financial Officer, said:

"I am honoured to have been appointed as Centrica CFO. The energy transition is happening now, and I'm excited by the opportunities which we have. I am looking forward to working with our 20,000 colleagues, the leadership team and the Board and to being a part of shaping the future for the Company."

ENDS

Enquiries:

Investors and AnalystsT: 01753 494900E: ir@centrica.com

MediaT: 01784 843000E: media@centrica.com

 

Notes:

 

Russell O'Brien's most recent role was as Group Treasurer at Royal Dutch Shell plc. Prior to this he has held a number of senior Chief Financial Officer roles within Royal Dutch Shell plc. He is a Management Accountant who graduated from St. Andrews university in 1995.

There are no additional details to be disclosed under Listing Rule 9.6.13 R.

 

Remuneration: 

The terms of Kate Ringrose's exit will be in accordance with Centrica's remuneration policy. In particular:

 

· Kate will be eligible to be considered for an annual bonus for the period worked during the 2023 financial year.

· Existing LTIP and RSP awards will be pro-rated based on the performance period that has elapsed at the point of termination and will vest on the normal vesting dates, subject to relevant performance conditions and underpins. Holding periods of 2 years will apply to any vested shares.

· A post-cessation shareholding requirement will apply in line with the Policy.

 

Details of the remuneration payable to Kate Ringrose will be disclosed on the Centrica website, in compliance with Section 430(2B) of the Companies Act 2006. Russell O'Brien's remuneration package will consist of a base salary, benefits and variable incentive arrangements which are in line with Centrica's remuneration policy. The key elements of the remuneration package are as follows:

· Base salary of £540,000.

· Pension contribution of 10% of base salary.

· Annual bonus maximum opportunity of 150% of salary.

· Annual Restricted Share Plan award of 125% of salary.

 

Incentives and other benefits will be in accordance with Centrica's remuneration policy.

Centrica plc is listed on the London Stock Exchange (CNA)Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654Legal Entity Identifier number: E26EDV109X6EEPBKVH76ISIN number: GB00B033F229

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABBMTTMTJBTMJ
Date   Source Headline
10th May 20246:00 pmRNSTransaction in Own Shares
10th May 20249:07 amRNSCentrica announces new issue and tender offer
9th May 20246:00 pmRNSTransaction in Own Shares
8th May 20246:00 pmRNSTransaction in Own Shares
7th May 20246:00 pmRNSTransaction in Own Shares
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:20 pmRNSAnnual Financial Report 2023
25th Mar 20246:00 pmRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20246:00 pmRNSTransaction in Own Shares
21st Mar 20246:00 pmRNSTransaction in Own Shares
20th Mar 20246:00 pmRNSTransaction in Own Shares
19th Mar 20246:00 pmRNSTransaction in Own Shares
18th Mar 20246:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.